Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

Anti-inflammatory activity of doxofylline and theophylline in LPS-induced lung inflammation

Yanira Riffo-Vasquez, Clive Page
European Respiratory Journal 2012 40: P2134; DOI:
Yanira Riffo-Vasquez
1Sackler Institute of Pulmonary Pharmacology, King's College London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clive Page
1Sackler Institute of Pulmonary Pharmacology, King's College London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Doxofylline and theophylline are two xanthine drugs that show both bronchodilator and anti-inflammatory actions. Data has suggested that doxofylline has a wider therapeutic window than theophylline however, the precise mechanism of action of doxofylline is unknown and its anti-inflammatory activity has not been widely investigated. Methods: Doxofylline (0.3 mg/kg i.p.) and Theophylline (10 mg/kg, i.p.) were given -24, -1 and 6 h after LPS (10 µg/mice, i.n.) in Balb/c mice. Lung lavage was performed 24 h later. In other experiments, doxofylline (0.3 mg/kg, i.p.) was given -24, -1 and 6 h after injection of LPS (10 µg) into the scrotal sac. Mice were prepared for intravital microscopy 24h later. Results: LPS recruited significantly higher number of neutrophils (PMN) to the lung (mean±SEM) compared to saline (saline:0±0 vs LPS:2.4±0.2 x106cells/ml, n =4). Doxofylline (Doxo) significantly inhibited the recruitment of PMN (LPS/Doxo:1.4±0.2 x106cells/ml, n =4; p<0.05 vs LPS alone). Theophylline (Theo) did not alter the recruitment of PMN in response to LPS (LPS:1.9±0.2 x106cells/ml vs LPS/Theo:2.5±0.2 x106cells/ml, n=8). Mice showed an accumulation of cells in the tissue (cells/50µm2) (saline:0±0 vs LPS:9.3±2.5, n=4; p<0.05) and higher number of cells rolling (cells x100µm2) in 30 sec (saline:0.2±0.2 vs LPS:5.3±2.4, n =4, p<0.05) 24 h after LPS injection into the scrotal sac. Doxofylline significantly inhibited cell migration in response to LPS (LPS/Doxo:3.1±1.9, n=4; p<0.05 vs LPS alone) but significantly increased cell rolling (10.2±3.0, n=4; p<0.05 vs LPS alone). Conclusion: Doxofylline significantly reduced cell transmigration in response to LPS, supporting an anti-inflammatory action.

  • Anti-inflammatory
  • Experimental approaches
  • Inflammation
  • © 2012 ERS
Previous
Back to top
Vol 40 Issue Suppl 56 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Anti-inflammatory activity of doxofylline and theophylline in LPS-induced lung inflammation
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Anti-inflammatory activity of doxofylline and theophylline in LPS-induced lung inflammation
Yanira Riffo-Vasquez, Clive Page
European Respiratory Journal Sep 2012, 40 (Suppl 56) P2134;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Anti-inflammatory activity of doxofylline and theophylline in LPS-induced lung inflammation
Yanira Riffo-Vasquez, Clive Page
European Respiratory Journal Sep 2012, 40 (Suppl 56) P2134;
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • RPL554, an inhaled PDE3/4 inhibitor, causes comparable bronchodilation to high dose nebulised salbutamol in asthmatics with fewer systemic effects
  • TRPM3: A regulator of airway sensory nerves and respiratory reflexes
  • Anti-inflammatory activity of the bradykinin B1R antagonist in a model of LPS-induced lung inflammation in cynomolgus monkey
Show more 5.1 Airway Pharmacology and Treatment

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society